The efficacy of Recove® topical ointment in pain alleviation, blister suppression, microbial control and wound healing in burn lesions
Phase 3
- Conditions
- Burn wound.Burns and corrosionsT20-T32
- Registration Number
- IRCT201606148177N15
- Lead Sponsor
- Tosan darou
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients between 12-70 years old with burn injury including grade 1 and 2 that have burned during 6 hours before admission.
Exclusion criteria: Dissatisfaction to enter the study; more than 10% TBSA burn; Need to be hospitalized; Burn wounds in head, face or genitalia; Electrical and Chemical Burns; Need to intravenous analgesic; Immunodeficiency; Diabetics; using Corticosteroid; uncontrolled hypertension; Withdrawing from the study; burn wound infection proved through clinical examination; Technical or human error in the process of treatment.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: First hour after dressing. Method of measurement: Numerical Scale.;Blister. Timepoint: first day. Method of measurement: Observation.;Microbial control. Timepoint: The 4th day. Method of measurement: Wound cultures in EMB& Blood Agar.;Wound healing. Timepoint: First day, 4th day, 10th day. Method of measurement: Photo and observation.
- Secondary Outcome Measures
Name Time Method